EMEA-000966-PIP01-10
Key facts
| Active substance |
Aqueous allergen extract of pollen from Phleum pratense
|
| Therapeutic area |
Pneumology-allergology
|
| Decision number |
P/335/2010
|
| PIP number |
EMEA-000966-PIP01-10
|
| Pharmaceutical form(s) |
Oral solution
|
| Condition(s) / indication(s) |
Treatment of allergic rhinitis / rhino-conjunctivitis
|
| Route(s) of administration |
Sublingual use
|
| Contact for public enquiries |
ROXALL Medizin GmbH
|
| Decision type |
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
|